f Purpose. The host response to allergens appears to be regulated by specific patterns of local cytokine production. More than 20,000 conjunctival superficial cells were collected with a special brush, a smaller version of the Cytobrush used in cervical cytology, from the upper palpebral conjuntiva.
Cytokines have been detected in conjunctival cells 5 by immunohistochemical analysis, and Th2-like T helper cells are present in the conjunctiva. 6 Mast cell lines produce lymphokines in response to cross-linkage of FceR I. 7 Interleukin 4 (IL-4) stimulates B cells to class-switching plasma cells diat produce immunoglobulin E (IgE). 8 " 10 Allergen and IgE combine to stimulate mast cells to secrete histamine and other inflammatory mediators. 11 Results reported in previous studies have shown the presence of mast cells in conjunctival samples 12 and IgE in tears, 13 " 17 and we have demonstrated increased levels of IL-4 in tears by enzyme-linked immunoabsorbant assay (ELISA). 18 Histamine and IL-4 are increased in cultured supernatants of samples in allergic conjunctivitis obtained by brush cytology. 19 Studies of lymphocyte signaling in mice indicate a complex series of regulatory interactions between lymphocyte subsets. In mice, clones of CD4-bearing T cells show divergence into Thl-and Th2-cell subpopulations. 1 The Thl cells produce the 1350 cytokines IL-2 and interferon (IFN)-y that are associated with delayed-type hypersensitivity reactions. The Th2 cells produce the interleukins IL-4, IL-5, and IL-13 that stimulate humoral responses. In humans, the divergence of CD4-bearing T cells into T h l and Th2 subsets has been less clear. However, certain infections and allergic diseases have shown a predominance of T h l -or Th2-like activity, respectively. 2 However, relatively little is known about the functional activity of CD4-bearing T cells at the actual site of allergic conjunctivitis. Therefore, to establish the involvement of these cytokines in allergic disease, we conducted the present study to further examine expression of T h 2 -like cytokines in conjunctival cytologic samples from patients with allergic conjunctivitis. In addition, we assayed the T-cell infiltration within these samples, and their HLA-DR (an activation marker) expression, which is also thought to be of importance in allergic tissue responses.
SUBJECTS AND METHODS

Patients and Healthy Subjects
Seven conjunctival cytology brush samples were obtained from seven patients with allergic conjunctivitis (seasonal allergic conjunctivitis), 20 three men and four women (aged 14 to 42; mean age ± SD of 28.9 ± 7.1 years), who visited the Department of Ophthalmology, Tokyo Dental College of Chiba, Japan, in March and April 1995. Allergic conjunctivitis was diagnosed based on history including symptoms of ocular itching, tearing, redness, or ocular pain with supportive slit-lamp examinations showing hyperemia or papilla formation of the palpebral conjunctiva and filamentous discharge, or the finding of cedar pollen-(Cryplomeria japonica) specific serum IgE antibody by the multiple antigen simultaneous test 16 (MAST 16) (SRL, Tokyo,Japan). 21 Seven conjunctival cell samples were obtained from seven age-and sex-matched healthy subjects (aged 22 to 32; mean age 28.2 ± 3.3 years) to serve as control samples. Healthy subjects had no symptoms or signs of allergic conjunctivitis and were negative for serum antigen-specific IgE antibody, according to results of the MAST 16 test. Informed consent for participation in the study was obtained from all participants. No corticosteroids, antihistamines, or mast cell-stabilizing agents were used for at least a 2-day period before samples were obtained.
Cell Sampling
Conjunctival epithelial cell specimens were collected by cytology brush from upper palpebral conjunctiva after topical anesthesia in a daily outpatient clinic. 22 ' 23 More than 20,000 conjunctival superficial cells were collected with a special brush (Cytobrush Small, Medscand, Malmo, Sweden) from the upper palpebral conjunctiva. These cells consisted primarily of epithelial cells, including some tears and mucin, in healthy subjects. 19 They were kept in 1 ml of phosphate-buffered saline. The number of cells were counted by a hemocytometer and divided for use in three experiments. After centrifugation at 120 X g at 4°C for 10 minutes, samples were frozen immediately in dry ice and stored at -80°C until processing for RNA extraction.
Giemsa Staining, Monoclonal Antibodies, and Immunohistochemistry Cytocentrifuge preparations were treated with MayGrunwald stain solution (Muto Pure Chemicals, Tokyo, Japan) and Giemsa stain (Daiichi Pure Chemicals, Tokyo, Japan). Lymphocytes were counted in four random fields that were chosen on the basis of the presence of an adequate number of cells. The percentage of all other cell types were compared. Monoclonal antibodies (mAbs) to detect human cell surface antigens including CD3 (pan T cell), CD4 (helper T cell), CD20 (pan B cell), and CD14 (macrophage) were obtained from Becton-Dickinson (Mountain View, CA) and anticytokeratin AE-3 was obtained from Boehringer Mannheim Biochemica (Indianapolis, IN) and was used as a conjunctival epithelial cell marker. Biotin-avidin immunoperoxidase staining was performed on acetone-fixed slides of samples. They were first stained with mAb, then with biotinlabeled goat antimouse Ig (Tago, Burlingame, CA), and finally with avidin-horseradish peroxidase (Vector, Burlingame, CA) and 3.3'-diaminobenzadine (Sigma, St. Louis, MO). All antibodies were diluted to give optimal staining results. Slides routinely were counterstained with hematoxylin.
Flow Cytometric Analysis
Flow cytometry (FACScan; Becton-Dickinson Immunocytometry System, Mountain View, CA) was performed on fixed laser power (600 mW at 488 nm) throughout the study. Standardization of the flow cytometer was achieved by measuring 4.05-//m fluorescent beads (Becton-Dickinson Immunocytometry System) that exhibited a constant light scatter and fluorescence. Background fluorescence reactivity was determined with IgG from control mice IgG. For the determination of HLA-DR expression, we used T cells from peripheral blood as a negative control and B cells from peripheral blood as a positive control. In this setting, expression of die antigen on positive controls was 100% and was < 5% on negative controls. Samples obtained by brush cytology from the patients and healdiy subjects were stained widi fluorescein isodiiocyanate (FITC) and photomultiplied to a voltage high enough diat die fluorescence histogram derived from die forward angle versus die side scatter-gated cell population, avoiding die lymphocytes and yielding a 1% to 5% background intensity of autofluorescence in die range ATGTACAGGATGCAACTCCTGTCTT GTCAGTGTTGAGATGATGCTITGAC ATGGGTCTCACCTCCCAACTGCT CGAACACTTTGAATATTTCTCTCTCAT AGCTGGCATGTACTGTGCAG TCGAATCTGGAGTCGGACAC ATGAAATATACAAGTTATATCTTGGCTTT GATGCTCTTCGACCTCGAAACAGCAT CCTTCCTGGGCATGGAGTCCTG GGAGCAATGATCTTGATCTTC reserved for positively FTTC-stained cells. For each sample, 10,000 cells were analyzed on a log fluorescence scale on the flow cytometer. To determine the keratin antigen, the mean log FITC-fluorescence channel of the positively stained cells was determined using a single-parameter histogram.
Samples from patients and healthy subjects were incubated with mouse anti-HLA-DR mAb (Becton-Dickinson) at 4°C for 30 minutes. After washing three times with phosphate-buffered saline-containing 2% fetal bovine serum, the samples were incubated with FITC-labeled goat antimouse IgG (Fab Fractions, Bio Source, Camarillo, CA) at 4°C for 30 minutes, and washed three times. The samples were run on a flow cytometer. For analyzing the expression of cytokeratin, the samples were fixed with 0.1% formaldehyde in phosphate-buffered saline, and permeabilized with digitonin (Sigma; 10 fig/ ml) at 4°C for 5 minutes. The permeabilized samples were stained with anticytokeratin AE-3 (Boehringer Mannheim Biochemica) and FITC-labeled goat antimouse IgG as described above.
Isolation and Amplification of RNA Cytokine mRNA expression in the conjunctival preparations was assayed by the reverse-transcription-polymerase chain reaction (RT-PCR) method. 23 With phenol from these mixtures, RNA was isolated, and a 20-ng sample was used for RT-PCR, with RNA reverse-transcribed into complementary DNA (cDNA). For cDNA synthesis, 20 ng of the sample RNA solution was heated at 65°C for 5 minutes. After the addition of 20 units of ribonuclease inhibitor (Takara, Kyoto, Japan), 1 fA of 10-fold-concentrated PCR buffer (500 mM KC1; 200 mM Tris-HCL, pH 8.4; 25 mM MgC^; 1 mg/ml bovine serum albumin), 1 fA of 1.25 mM dNTPs (dATP, dCTP, dGTP, dTTP from Pharmacia LKB Biotechnology, Uppsala, Sweden), 10 parts hexanucleotide mixture (Boehringer Mannheim, Germany), 0.1% dithiothreitol (Aldrich Chemical, Milwaukee, WI), and 20 units of reverse transcriptase (200 U/ml; Perkin Elmer-Cetus, Norwalk, CT) were added to the RNA solution. The reverse-transcription reaction was carried out at 42°C for 60 minutes, 94°C for 5 minutes.
To perform the PCR assay, 10 fA of the cDNA reaction mixture was diluted with 90 fA of PCR buffer, followed by the addition of 20 pmol of 5' and 3' primers, 1.25 mM dNTPs, 20 mM MgCl 2 , and 2 units of thermostable Taq polymerase (Perkin Elmer-Cetus) and was overlaid with 150 fA of mineral oil. The reaction was started by denaturing the RNA-cDNA hybrid by heating at 94°C for 45 seconds, annealing the primers at 60°C for 45 seconds, and extending the primers at 72°C for 2 minutes. Amplification was performed with a DNA thermal cycler (Perkin Elmer-Cetus). After being denaaired at 94°C for 10 minutes, the reaction mixture was passed through 35 cycles consisting of 94°C for 45 seconds, 55°C for 45 seconds, and 72°C for 2 minutes, with a final extension for 7 minutes at 72°C. 24 Then, 10-/J.1 samples of the PCR products were analyzed by electrophoresis on a 1.7% agarose gel containing ethidium bromide. The specificity of the amplified products was validated by their predicted size on the agarose gel. To confirm the PCR reaction, the amplified products were purified by electrophoresis on a 4% Nusieve (FMC, Rockland, ME) agarose gel. The predominant band was cut out of the gel and placed in 0.1 ml of TE (0.01M Tris-HCL, pH 8; 0.1 mM EDTA). Gel-purified PCR products were ligated into PT7 blue vector. Dideoxynucleotide chain-termination sequencing was performed according to the manufacturer's protocol. Three independent clones were sequenced.
Peripheral blood mononuclear cells (2 X 10 7 cells) were stimulated for 24 hours with 50 U/ml recombinant IL-2 and 1 /xg/ml phytohemagglutinin for use as positive controls for all cytokines.
Synthesis of Primers and Probes
Interleukins IL-2, 25 ' 26 IL-4, 27 and IFN-y 28 and /3-actin 29 specific primers were obtained (Clontech Laboratories, Palo Alto, CA) and IL-13, was synthesized on model 391 PGR-Mate (Applied Biosystems, Foster City, CA) and purified on Sephadex G50 columns (Pharmacia LKB Biotechnology) and by high-performance liquid chromatography. 30 This primer sequence was specific and showed no significant homology, as confirmed by a computer-assisted search of updated versions of GenBank, and were chosen with a balanced nucleotide composition ranging from 40% to 60% glycine cystein content (Table 1) .
Statistical Analyses
Data are shown as the mean ±SD. Statistical analysis of superficial cells and HLA-DR were performed using the unpaired, two-tailed Student's ttest, and analysis of expression of cytokines was performed using Fisher's exact test, with a level of P < 0.05 accepted as statistically significant. 
RESULTS
Giemsa and Immunohistochemical Staining
The mean cells collected from 14 samples was 26,400 ± 10,700. May-Grunwald-Giemsa staining of cytocentrifuged preparations from patients with allergic conjunctivitis showed conjunctival epithelial cells with lymphocytes, mast cells, and eosinophils. Higher numbers of lymphocytes (mean, 3.6 ± 1.5%) were obtained in samples from allergic patients tiian in sam- pies from healthy subjects (mean, 0.4 ± 0.5%; P = 0.0002: Student's 2-test). Results of an immunohistochemical study using mAbs showed a few CD3-and CD4-bearing cells in allergic patients, but no CD20-and CD14-bearing cells (Figs. 1, 2) . None of these cells were seen in samples from healthy control subjects, but AE-3-expressing conjunctival epithelial cells were seen.
Flow Cytometric Analysis for HLA-DR Expression
Expression of HLA-DR was observed in 82.6 ± 1 7 % of conjunctival epithelial cells obtained from allergic patients compared with 34.2 ± 17.8% of those cells obtained from healthy subjects (P = 0.0001; unpaired Student's /-test; Fig. 3 ).
Analysis of Clinical Samples
A marked expression of IL-4 transcript was observed in six samples, and IL-13 was observed in seven samples from seven patients with allergic conjunctivitis. In contrast, IL-2 and IFN-y were not found in the samples from allergic patients (Fig. 4A) . Transcripts of IL-4 and IL-13 were weakly visualized in one healthy subject. No cytokine expression was detected in die other samples from healthy subjects (Fig. 4B ). There was a significant difference in the expression of IL-4 (P = 0.005; Fisher's exact test) and IL-13 (P = 0.029) between patients and healthy subjects.
DISCUSSION
To determine the T-cell-cytokine-mRNA profile in the cell samples, which were obtained by brush cytology and included various cell types, we have examined the population of eosinophils, CD3-, CD4-, CD14-, CD20-, and AE-3-expressing conjunctival epithelial cells by immunocytology. Giemsa and immunohistochemical staining of cytocentrifuged preparations showed that most conjunctival cells obtained from healthy subjects were epithelial cells. Cell samples from patients with allergic conjunctivitis showed small numbers of inflammatory cells, including lymphocytes, mast cells, and eosinophils, but an increased percentage of lymphocytes. 19 Lymphocytes are usually present in the substantia propria and may have been loosened by edema.' 2 We previously detected histamine and IL-4 in cell samples obtained from patients with seasonal allergic conjunctivitis. 19 Expression of HLA-DR was also observed with greater frequency in cell samples from the allergic patients compared with that in samples from healthy subjects. The expression of HLA-DR antigen on conjunctival cells is regulated by T cells. 31 Because HLA-DR is an activation marker, our flow cytometric data imply that activation of conjunctival epithelial cells is present in patients with allergic conjunctivitis. Our results suggest that activation of Th2 cytokine expression may lead to HLA-DR expression in conjunctival epithelial cells, implying a linkage with pathology of allergic conjunctivitis.
Two subsets of helper T cells, designated Thl and Th2, have been characterized in mouse and humans, and a linkage of the Th2 pattern to allergic disease has been demonstrated. 1 ' 6 ' 32 ' 33 We have detected IL-2, IFN-7, IL-4, and IL-13 expression by RT-PCR to define the divergence into Thl and Th2 subpopulations. The different spectra of cytokines produced by these cell types is critical to their definition. In our study's findings the pattern of steady state mRNA expression determined by RT-PCR of cells from patients with allergic conjunctivitis differs from that in cells from healthy subjects. The observation of T lymphocytes in cell samples from patients with allergic conjunctivitis and the demonstration of cells expressing mRNA for IL-4 3 "' 34 and IL-13, but not IFN-y, suggest that Th2-like helper T cells may participate in allergic conjunctivitis.
Recently, the cDNA encoding IL-13, a T cell-derived cytokine, was cloned and expressed. Interleukin-13 induced IgG 4 and IgE synthesis by human B cells IL-4-independently.
303t> Because IL-13 is produced for a much longer period after T-cell activation than IL-4, it has been suggested that IL-13 has an important role in the regulation of prolonged IgE synthesis in allergic disease. 35 Transcript for this cytokine was demonstrated in cell samples from patients with allergic conjunctivitis and in one healthy subject in the current study. The weak expression of IL-4 and IL-13 transcript in a single healthy subject may have been caused by other atopic or allergic disease that was not discovered on initial selection. By immunocytologic analysis, only a small number of T cells and other inflammatory cells were stained, with the majority of cells obtained by brush cytology identified as epithelial cells. Conjunctival epithelial cells express HLA-DR in trachoma,* 6 CD54 adhesion molecules in allergic conjunctivitis, 37 cytokines in ocular pemphigoid 5 and Th2-like cytokines in vernal conjunctivitis. 6 Conjunctival cells may play a role in allergic disease, and it is possible that IL-4, produced by conjunctival epithelial cells, could promote development of Th2. 38 ' 39 The separation of conjunctival epithelial cells from lymphocytes by brush cytology will be necessary to study the source of IL-4 further. Accordingly, die large population of conjunctival epithelial cells must be studied more precisely. Aldiough we have previously described levels of IL-4 in antigen stimulate peripheral blood lymphocytes in patients with allergic conjunctivitis, 40 results from this study demonstrated that the Th2-like cytokine is transcripted at the ocular surface where the allergic reaction is occurring. The local proinflammatory cytokine milieu may have played an important role in allergic conjunctivitis.
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